Blood Reviews
Volume 20, Issue 6 , Pages 333-342, November 2006

Tumor microenvironment and drug resistance in hematologic malignancies

  • Zhi-Wei Li

      Affiliations

    • H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, SBR-2, Tampa, FL 33612, United States
    • Tel.: +813 745 2123; fax: +813 979 7265.
  • ,
  • William S. Dalton

      Affiliations

    • H. Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, SBR-CEO, Tampa, FL 33612, United States
    • Corresponding Author InformationCorresponding author. Tel.: +813 615 4261; fax: +813 615 4258.

published online 22 August 2006.

Summary 

Increasing evidence supports the role of the tumor microenvironment in conferring drug resistance as a major cause of relapse and incurability of cancers. The tumor microenvironment consists of normal stromal cells, extracellular matrix, and soluble factors such as cytokines and growth factors. Tumor-tumor cell interaction, tumor-stromal cell interaction, as well as tumor-ECM interaction, all contribute to direct cell contact mediated drug resistance. In addition, soluble factors produced in the tumor microenvironment provide further signals for tumor cell growth and survival. Environment mediated-drug resistance (EM-DR) could be considered as the totality of cell adhesion mediated drug resistance (CAM-DR) and soluble factor mediated drug resistance (SM-DR) produced by the tumor-host interaction. This review focuses on the EM-DR model system and signaling pathways involved in cell survival of hematological malignancies.

Keywords: Drug resistance, Tumor microenvironment, EM-DR, CAM-DR, SM-DR, Cell adhesion

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0268-960X(05)00043-3

doi:10.1016/j.blre.2005.08.003

Blood Reviews
Volume 20, Issue 6 , Pages 333-342, November 2006